Identifying conserved DR1501-restricted CD4+ T-cell epitopes in avian H5N1 hemagglutinin proteins

Viral Immunology

Volumn 23, Issue 6, 2010, Pages 585-593

  Wang, Sheng Fan ^a   Yao, Ling ^a   Liu, Shih Jen ^c   Chong, Pele ^c   Liu, Wu Tse ^a   Chen, Yi Ming Arthur ^a,c   Huang, Jason C ^a,b,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HEMAGGLUTININ; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; HLA DR1051 ANTIGEN; INFLUENZA VACCINE; INFLUENZA VIRUS A H5N1 VACCINE; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; DR1501 GENE; DRUG EFFICACY; GENE FREQUENCY; GENOTYPE; HUMAN; INFLUENZA; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H5N1 INFECTION; INOCULATION; MONITORING; NONHUMAN;

AMINO ACID SEQUENCE; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL CULTURE TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HISTOCOMPATIBILITY TESTING; HLA-DR ANTIGENS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; MOLECULAR SEQUENCE DATA;

AVES;

EID: 78650114721     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2010.0058     Document Type: Article

References (34)

1. Boon AC, Fringuelli E, Graus YM, et al.: Influenza A virus specific T cell immunity in humans during aging. Virology 2002;299:100-108.
2. Brett SJ, Blau J, Hughes-Jenkins CM, Rhodes J, Liew FY, and Tite JP: Human T cell recognition of influenza A nucleopro-tein. Specificity and genetic restriction of immunodominant T helper cell epitopes. J Immunol 1991;147:984-991.
3. Brocker T, Riedinger M, and Karjalainen K: Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J Exp Med 1997;185:541-550.
4. Carrat F, and Flahault A: Influenza vaccine: the challenge of antigenic drift. Vaccine 2007;25:6852-6862.
5. Carter NJ, and Plosker GL: Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted) [Prepandrix]: a review of its use as an active immunization against influenza A subtype H5N1 virus. BioDrugs 2008;22:279-292.
6. Cecconi V, Moro M, Del Mare S, Dellabona P, and Casorati G: Use of MHC class II tetramers to investigate CD4\+ T cell responses: problems and solutions. Cytometry A 2008;73: 1010-1018.
7. Chang HC, Bao Z, Yao Y, et al.: A general method for facilitating heterodimeric pairing between two proteins: application to expression of alpha and beta T-cell receptor extracellular segments. Proc Natl Acad Sci USA 1994; 91:11408-11412.
8. Chicz RM, Urban RG, Lane WS, Gorga JC, Stern LJ, Vignali DA, and Strominger JL: Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 1992;358: 764-768.
9. Cunliffe SL, Wyer JR, Sutton JK, et al.: Optimization of peptide linker length in production of MHC class II/peptide tetrameric complexes increases yield and stability, and allows identification of antigen-specific CD4\+ T cells in peripheral blood mononuclear cells. Eur J Immunol 2002; 32:3366-3375.
10. Danke NA, and Kwok WW: HLA class II-restricted CD4\+ T cell responses directed against influenza viral antigens postinfluenza vaccination. J Immunol 2003;171:3163-3169.
11. Davenport FM: Control of influenza. Med J Aust Suppl 1973;33-38.
12. Gauduin MC: Intracellular cytokine staining for the characterization and quantitation of antigen-specific T lymphocyte responses. Methods 2006;38:263-273.
13. Gocnik M, Fislova T, Mucha V, Sladkova T, Russ G, Kos-tolansky F, and Vareckova E: Antibodies induced by the HA2 glycopolypeptide of influenza virus haemagglutinin improve recovery from influenza A virus infection. J Gen Virol 2008;89:958-967.
14. Graham CM, Warren AP, and Thomas DB: Do antigenic drift residues in influenza hemagglutinins of the H3 subtype qualify as contact sites for MHC class II interaction? Int Immunol 1992;4:917-922.
15. Haghighi HR, Read LR, Haeryfar SM, Behboudi S, and Sharif S: Identification of a dual-specific T cell epitope of the hemagglutinin antigen of an h5 avian influenza virus in chickens. PLoS One 2009;4:e7772.
16. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Git-tleman JL, and Daszak P: Global trends in emerging infectious diseases. Nature 2008;451:990-993.
17. Korteweg C, and Gu J: Pathology, molecular biology, and pathogenesis of Avian influenza A (H5N1) infection in humans. Am J Pathol 2008;172:1155-1170.
18. Kraan J, Arroz M, Keeney M, Freire M, Weir K, Heijnen I, and Gratama JW: Flow cytometric enumeration of Class I HLA-restricted, peptide-specific CD8\+ T lymphocytes using tetramer technology and single-platform absolute T-cell counting. J Biol Regul Homeost Agents 2003;17:268-278.
19. Kwok WW, Gebe JA, Liu A, et al.: Rapid epitope identification from complex class-II-restricted T-cell antigens. Trends Immunol 2001;22:583-588.
20. Lin M, Chu CC, Chang SL, et al.: The origin of Minnan and Hakka, the so-called "Taiwanese", inferred by HLA study. Tissue Antigens 2001;57:192-199.
21. Nicholson KG, Wood JM, and Zambon M: Influenza. Lancet 2003;362:1733-1745.
22. Novak EJ, Liu AW, Gebe JA, Falk BA, Nepom GT, Koelle DM, and Kwok WW: Tetramer-guided epitope mapping: rapid identification and characterization of immunodominant CD4\+ T cell epitopes from complex antigens. J Immunol 2001;166:6665-6670.
23. Parida R, Shaila MS, Mukherjee S, Chandra NR, and Nayak R: Computational analysis of proteome of H5N1 avian influenza virus to define T cell epitopes with vaccine potential. Vaccine 2007;25:7530-7539.
24. Prabhu N, Prabakaran M, Ho HT, Velumani S, Qiang J, Goutama M, and Kwang J: Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection. J Virol 2009;83:2553-2562.
25. Reijonen H, and Kwok WW: Use of HLA class II tetramers in tracking antigen-specific T cells and mapping T-cell epi-topes. Methods 2003;29:282-288.
26. Roti M, Yang J, Berger D, Huston L, James EA, and Kwok WW: Healthy human subjects have CD4\+ T cells directed against H5N1 influenza virus. J Immunol 2008;180: 1758-1768.
27. Scheibenbogen C, Lee KH, Stevanovic S, et al.: Analysis of the T cell response to tumor and viral peptide antigens by an IFNgamma-ELISPOT assay. Int J Cancer 1997;71:932-936.
28. Seo SH, and Webster RG: Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets. J Virol 2001;75:2516-2525.
29. Seo SH, and Webster RG: Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells. J Virol 2002;76:1071-1076.
30. Van Overtvelt L, Wambre E, Maillere B, et al.: Assessment of Bet v 1-specific CD4\+ T cell responses in allergic and non-allergic individuals using MHC class II peptide tetramers. J Immunol 2008;180:4514-4522.
31. Wang SF, Chen KH, Thitithanyanont A, et al.: Generating and characterizing monoclonal and polyclonal antibodies against avian H5N1 hemagglutinin protein. Biochem Biophys Res Commun 2009;382:691-696.
32. Yamada S, Suzuki Y, Suzuki T, et al.: Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 2006;444:378-382.
33. Yang J, James EA, Huston L, Danke NA, Liu AW, and Kwok WW: Multiplex mapping of CD4 T cell epitopes using class II tetramers. Clin Immunol 2006;120:21-32.
34. Ye M, Kasey S, Khurana S, et al.: MHC class II tetramers containing influenza hemagglutinin and EBV EBNA1 epi-topes detect reliably specific CD4(\+) T cells in healthy volunteers. Hum Immunol 2004;65:507-513.